Emerging data suggest this peptide, a dual stimulator targeting both GLP-1 and another hormone, could represent a significant step forward for weight treatment. Preliminary patient investigations have indicated impressive losses in abdominal mass , possibly exceeding current body composition therapies . However , additional assessment is needed to